Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$20.69 - $20.91 $33.7 Million - $34.1 Million
1,629,864 Added 197.32%
2,455,847 $51.3 Million
Q2 2022

Aug 15, 2022

SELL
$13.8 - $20.82 $3.41 Million - $5.14 Million
-246,993 Reduced 23.02%
825,983 $17.1 Million
Q1 2022

May 16, 2022

BUY
$15.96 - $18.87 $15.8 Million - $18.7 Million
991,966 Added 1224.5%
1,072,976 $18 Million
Q4 2021

Feb 14, 2022

SELL
$16.79 - $20.37 $3.66 Million - $4.43 Million
-217,693 Reduced 72.88%
81,010 $1.62 Million
Q3 2021

Nov 15, 2021

BUY
$18.14 - $27.03 $2.49 Million - $3.71 Million
137,287 Added 85.05%
298,703 $5.42 Million
Q2 2021

Aug 16, 2021

BUY
$25.24 - $30.86 $1.81 Million - $2.21 Million
71,611 Added 79.74%
161,416 $4.36 Million
Q1 2021

May 17, 2021

BUY
$28.29 - $39.89 $835,149 - $1.18 Million
29,521 Added 48.97%
89,805 $2.69 Million
Q4 2020

Feb 16, 2021

SELL
$24.45 - $31.59 $1.79 Million - $2.31 Million
-73,248 Reduced 54.85%
60,284 $1.73 Million
Q3 2020

Nov 16, 2020

SELL
$17.22 - $24.59 $908,079 - $1.3 Million
-52,734 Reduced 28.31%
133,532 $3.26 Million
Q2 2020

Aug 14, 2020

SELL
$6.46 - $19.27 $2.48 Million - $7.39 Million
-383,371 Reduced 67.3%
186,266 $3.33 Million
Q1 2020

May 15, 2020

BUY
$5.64 - $15.23 $2.83 Million - $7.63 Million
501,000 Added 729.93%
569,637 $4.64 Million
Q4 2019

Feb 14, 2020

SELL
$8.8 - $14.93 $6.29 Million - $10.7 Million
-714,289 Reduced 91.23%
68,637 $906,000
Q3 2019

Nov 14, 2019

BUY
$11.76 - $25.57 $7.31 Million - $15.9 Million
621,244 Added 384.24%
782,926 $9.31 Million
Q2 2019

Aug 14, 2019

BUY
$22.88 - $33.27 $2.27 Million - $3.3 Million
99,110 Added 158.39%
161,682 $3.96 Million
Q1 2019

May 15, 2019

BUY
$31.52 - $46.19 $1.97 Million - $2.89 Million
62,572 New
62,572 $0

Others Institutions Holding CVET

About COVETRUS, INC.


  • Ticker CVET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 140,123,008
  • Description
  • Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...
More about CVET
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.